Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00002954
DRKS00002954
Completed
Not Applicable

The effect of radiation therapy of the prostate on parameters, which can be acquired by magnetic resonance tomography: relaxation times, apparent diffusion coefficient and perfusion. - N/A

niversitätsklinikum Freiburg0 sites6 target enrollmentMay 9, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC61Malignant neoplasm of prostate

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C61
Sponsor
niversitätsklinikum Freiburg
Enrollment
6
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 9, 2012
End Date
December 31, 2013
Last Updated
last year
Study Type
Observational
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Male patients older than 18 years, with histologically confirmed prostate cancer.
  • •\- Where the biopsy at the time of the first MR examination at least 6 weeks is back
  • •\- The radiation therapy can be obtained as primary therapy (5 x 2 Gy / week up to a total dose of 72\-76 Gy)
  • •\- Have no restriction on the kidney function.
  • •\- No contraindications for the whole\-body MRI
  • •\- Consent to participate in the study after detailed explanation of previous and written consent

Exclusion Criteria

  • •\- TURP prior to study inclusion
  • •\- Pre\-irradiation in the pelvic area
  • •\- Start an anti\-hormonal therapy prior to study entry
  • •\- Contraindications to MR studies (pacemakers, metallic clips after magnetizable brain or heart surgery, cochlear implants, metallic foreign body in the eye, insulin pumps, etc.).
  • •\- Ferromagnetic intracorporeal debris
  • •\- SM / AICD implantation
  • •\- Lack of written informed consent
  • •\- Combined radiation therapy (HDR afterloading percutaneous)
  • •\- Severe allergic diathesis
  • •\- Known allergy to contrast agent gadolinium\-chelates

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Radiation sensitivity in prostate cancer patientsProstate CancerCancer - Prostate
ACTRN12605000538640ROYAL ADELAIDE HOSPITA100
Completed
Not Applicable
Radiotherapy for prostate cancer: Influence of fiducial marker on diffusion weighted MR image
JPRN-UMIN000036326Asahi University20
Completed
Phase 2
A trial of prostate radiotherapy in conjunction with carbogen and nicotinamideProstate cancerCancerMalignant neoplasm of prostate
ISRCTN08912168East and North Hertfordshire Hospitals NHS Trust (UK)50
Active, not recruiting
Phase 1
Prostate Radiotherapy with Oxygen EnhancementTherapeutic area: Diseases [C] - Cancer [C04]Prostate CancerMedDRA version: 14.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2010-021886-63-GBEast and North Hertfordshire NHS Trust50
Completed
Not Applicable
Research on radiation therapy for prostate ductal carcinoma and small cell carcinomaprostate ductal carcinoma and small cell carcinoma
JPRN-UMIN000037617Japanese Radiation Oncology Study Group100